SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-064905
Filing Date
2020-12-22
Accepted
2020-12-22 18:16:37
Documents
2
Period of Report
2020-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7283
2 EX-24 DOCUMENT attachment1.htm EX-24 4291
  Complete submission text file 0001209191-20-064905.txt   12961
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 2 MERCER ROAD NATICK MA 01760
Business Address
Mirza Mansoor Raza (Reporting) CIK: 0001588389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 201409283